関連する実験動画
Updated: Jun 23, 2026

10:09
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
小分子阻害剤の複数の独立した結合部位がオンコタンパク質c-Myc上にある
Dalia I Hammoudeh1, Ariele Viacava Follis, Edward V Prochownik
1Department of Chemistry, Georgetown University, Washington, District of Columbia 20057, USA.
Journal of the American Chemical Society
|May 13, 2009
まとめ
研究者らは,小分子阻害剤のc-Mycオンコタンパク質に3つの異なる結合部位を特定しました. これらの部位は,同時に独立して結合し,c-Mycを保存することを可能にします.
科学分野:
- バイオケミストリー バイオケミストリー
- 腫瘍学 腫瘍学
- 構造生物学 構造生物学とは
背景:
- c-Mycトランスクリプションファクタは,がんでは頻繁に規制解除され,重要な治療標的となっています.
- Maxでc-Mycの二酸化を阻害することは,その腫瘍性活性を阻害する戦略です.
- c-Mycの基本的なヘリックス・ループ・ヘリックス・レウシン・ジッパー (bHLHZip) ドメインは,モノマーとして本質的に乱れている (ID).
研究 の 目的:
- モノメアcc-Myc bHLHZipドメインの小分子結合部位を特定し,特徴づけること.
- 既知のc-Myc-Max阻害剤による阻害メカニズムを調査する.
- 癌治療のために本質的に乱れたタンパク質を標的とする可能性を調査する.
主な方法:
- 円形の二重化スペクトロスコピー
- 光ポラライゼーションアッセイ
- 核磁共振 (NMR) スペクトロスコーピーは,核磁共振 (NMR) スペクトロスコーピーのスペクトロスコーピーを用います.
主要な成果:
- c-Myc bHLHZip領域内に3つの離散的な小分子結合部位が特定されました.
- テストされた7つのMyc阻害剤はすべて,この3つの部位のうちの1つに結合します.
- 阻害剤の結合は局所的な形状の変化を引き起こすが,全体的なタンパク質の乱れを保ち,二分化を阻害する.
- ある部位への結合は,他の部位での結合親和性や構造変化に影響を与えず,同時に独立した結合を可能にします.
結論:
- c-Myc bHLHZipドメインは,複数の独立した小分子結合部位を有する.
- これらの発見は,ID配列をターゲットにすることで,本質的に乱れたタンパク質を含むタンパク質-タンパク質相互作用を抑制するための合理的で汎用的なアプローチを支持します.
- この戦略は,新しいがん治療法の開発に有望である.
関連する概念動画
Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
